FDA data Registry peer set 2 peers

Alternatives to nebivolol

2 same-class SPL records vs nebivolol - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Bystolic

Beta-1 Selective Blocker Prescription 2 alternatives found

About nebivolol

Nebivolol is a medicine that lowers high blood pressure. Lowering blood pressure helps prevent strokes and heart attacks.

Used for: Nebivolol treats high blood pressure. High blood pressure increases your risk of heart attack and stroke. Nebivolol can be used alone or with other blood pressure medicines.

2 Beta-1 Selective Blocker peers (wide set)

Compare nebivolol vs atenolol side-by-side →

nebivolol vs atenolol & bisoprolol · FAERS reaction fields

FAERS top-reaction field "Diarrhoea" shows the widest count spread between nebivolol and atenolol, bisoprolol in this extract (6,275-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect nebivolol atenololbisoprolol
Acute Kidney Injury 922 - -
Dyspnoea 773 6,276 -
Diarrhoea 724 6,999 -
Drug Interaction 616 - -
Hypotension 611 3,689 -
Anaemia 598 - -
Nausea 573 7,813 -
Fatigue 519 7,573 -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

nebivolol peer mix vs class inventory

Peer mix

0 OTC and 2 Rx SPL records in this peer set (2 total). Class inventory for Beta-1 Selective Blocker: 3 drugs.

Frequently Asked Questions

What same-class SPL records sit beside nebivolol?
This registry lists 2 Beta-1 Selective Blocker medication records beside nebivolol, including atenolol, bisoprolol. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Beta-1 Selective Blocker peer set (2 records)

nebivolol (Bystolic) sits in a wide Beta-1 Selective Blocker peer set (2 of 2 class peers shown). Labeled indication field for nebivolol: Nebivolol treats high blood pressure.

Top FAERS reaction fields for nebivolol total 6,326 reports across 10 reactions, set beside atenolol, bisoprolol. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full nebivolol profile →

Field note for nebivolol: see also the generic vs brand label guide when reading Bystolic SPL strings.